ArticleJournal of medical cases2022

Novel Treatment of Ventilator Dyssynchrony From Central Alveolar Hypoventilation Syndrome Utilizing Scheduled 5-Hydroxytryptamine-3 Receptor Antagonist.

Aldin Malkoc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.